• Reinventing for returns: what's next in pharma?

  • 2024/03/13
  • 再生時間: 14 分
  • ポッドキャスト

Reinventing for returns: what's next in pharma?

  • サマリー

  • Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.

    Key topics include:

    • The headwinds for pharma are real and sustained
    • Rethinking the innovation strategy
    • Accelerate using AI and analytics
    • Lower costs
    • M&A as a catalyst for transformation
    • Protecting the enterprise

    Speakers:

    Jenny Colapietro, Health Industries Vice Chair, PwC
    Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC
    Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC


    For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

    続きを読む 一部表示

あらすじ・解説

Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.

Key topics include:

  • The headwinds for pharma are real and sustained
  • Rethinking the innovation strategy
  • Accelerate using AI and analytics
  • Lower costs
  • M&A as a catalyst for transformation
  • Protecting the enterprise

Speakers:

Jenny Colapietro, Health Industries Vice Chair, PwC
Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC
Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC


For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Reinventing for returns: what's next in pharma?に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。